Translation regulation after taxol treatment in NIH3T3 cells involves the elongation factor (eEF)2

Area of Science:

• Cell Biology
• Molecular Biology
• Cancer Research

Background:

• Apoptosis involves modifications to the translational machinery, including protein phosphorylation and proteolytic cleavage.
• Taxol (paclitaxel) is an anti-cancer drug that induces apoptosis via calpain activation.
• Previous work demonstrated Taxol induces calpain-mediated apoptosis in NIH3T3 cells.

Purpose of the Study:

• To investigate the mechanisms of translation inhibition during Taxol-induced apoptosis.
• To determine the roles of specific translation factors (eIF2a, eIF4E, eIF4G, 4E-BP1) and eEF2 phosphorylation in Taxol-induced translation inhibition.

Main Methods:

• Treatment of NIH3T3 cells with Taxol and MDL28170 (calpain inhibitor).
• Analysis of phosphorylation status and expression levels of translation factors (eIF2a, eIF4E, eIF4G, 4E-BP1, eEF2).
• Measurement of protein synthesis inhibition.

Main Results:

• Taxol treatment significantly inhibited protein synthesis during apoptosis.
• Taxol decreased expression of eIF4G, eIF4E, and 4E-BP1, but not eIF2a phosphorylation.
• Calpain inhibition partially rescued eIF4G levels but did not affect eIF4E, 4E-BP1, or translation inhibition.
• Taxol increased eEF2 phosphorylation in a calpain-independent manner.

Conclusions:

• The studied translation initiation factors are not responsible for Taxol-induced protein synthesis inhibition.
• Increased eEF2 phosphorylation plays a role in Taxol-induced translation inhibition during apoptosis.